Thyroid carcinoma in Pakistan A retrospective review of 998 cases from an academic referral center by Bukhari, Uzma et al.
original research report
Hematol Oncol Stem Cell Ther 2(2)  Second Quarter 2009 hemoncstem.edmgr.com 345
The reported rate of thyroid carcinoma among all malignancies is approximately 1%.1 In Saudi Arabia, thyroid cancer was the second most 
common malignancy after breast cancer,2 while it was 
reported as the third most common in in the United 
Arab Emirates3 and fourth most common cancer in 
Filipino women.4
The reported age-standardized incidence ratio of 
thyroid cancer per 100 000 population in different 
parts of the world varies from 0.8 to 0.5 for males and 
1.9 to 19.4 for females.5 The life-time risk of develop-
ing thyroid cancer in the US is about 1:120 for females 
while the risk of dying from the disease is approxi-
mately 1 in 1700.6
The cause of thyroid carcinoma is not known, but 
there are some predisposing factors. Head and neck ir-
radiation in childhood is a known predisposing factor, 
mainly for the papillary type.7 There is also experimental 
evidence suggesting an association between prolonged 
high levels of thyroid stimulating hormone (TSH) and 
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BACKGROUND AND OBJECTIVES: to address the need for epidemiologic data on thyroid carcinoma in 
pakistan, we evaluated the frequency and types of thyroid carcinoma with respect to age and sex.
METHODS: in a a retrospective study conducted at the Jinnah postgraduate medical centre in Karachi, we 
reviewed thyroid lesions reported over a period of 5 years, from July 2000 to June 2005. pathology slides were 
studied to determine the types and frequencies of malignant lesions of the thyroid. 
RESULTS: of 998 thyroid lesions reviewed, 153 cases were malignant. papillary carcinoma was the common-
est malignant lesion with a frequency of 90.2%, followed by 4.5% for medullary carcinoma, 2% for follicular 
carcinoma, 2% for undifferentiated carcinoma and 0.7% each for mixed medullary and papillary carcinoma 
and poorly differentiated carcinoma. females were predominant (82.4%) as compared with males (17.6%) for a 
female-to-male ratio 4.7:1. the maximum number of the patients were in the fourth decade of life followed by 
the third and second decades.
CONCLUSION: the commonest malignant thyroid lesion was papillary carcinoma. thyroid cancer was more com-
mon in females. papillary, medullary and follicular carcinomas were found in patients in the third and fourth decades 
of life, while poorly and undifferentiated carcinomas were diagnosed from the fifth to seventh decades of life.
thyroid follicular adenoma and carcinoma.8 Moreover, 
iodine deficient areas are known to have a high frequen-
cy of follicular carcinoma.9
Unfortunately, the incidence of thyroid carcinoma in 
Pakistan is difficult to assess due to the lack of popu-
lation-based statistics, but its relative frequency in our 
country is on the increase.10 The increase in frequency 
in our population could be due to awareness of this dis-
ease and other factors including genetic, dietary and en-
vironmental factors.11 Information on the geographical 
distribution of cancer has been of great value for gen-
eration of epidemiologic hypothesis and formulation of 
concepts for the etiology of cancer. Such information 
would also be valuable for making global comparisons. 
In an effort to address this need, we attempted to deter-
mine the frequency and types of different carcinomas 
received over a period of five years.
METHODS
This was a retrospective study carried out in the 
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Department of Pathology, Basic Medical Sciences 
Institute, Jinnah Postgraduate Medical Centre, Karachi, 
Pakistan. Thyroid lesions seen over a 5-year period from 
July 2000 to June 2005 were reviewed and cases of ma-
lignant lesions were selected for detailed study. Special 
stains like periodic acid-Schiff (PAS), trichrome and 
Congo red were performed whenever required. The 
clinical history and relevant data such as age and sex 
was obtained from the records.
RESULTS
Of 998 thyroid lesions reviewed, 153 cases were diag-
nosed as malignant lesions. Of these, papillary carcino-
ma was the commonest thyroid carcinoma with a total 
of 138 (90.2%). There were 7 (4.5%) cases of medullary 
carcinoma followed by 3 (2%) cases each of follicular 
and undifferentiated carcinoma, while 1 (0.7%) case 
each of mixed medullary and papillary carcinoma and 
poorly differentiated carcinoma were seen (Table 1). 
Of 138 papillary carcinomas, 72 cases were follicular 
variants followed by 61 cases of classic papillary carci-
noma and 5 cases of micropapillary carcinoma. Of the 7 
cases of medullay carcinoma, 3 were the follicular vari-
ant and there was one case each of papillary, small cell, 
paraganglioma like and oncocytic variant of medullary 
carcinoma was seen.
Females were predominant with a total of 126 
(82.4%) as compared to males with a total of 27 
(17.6%). The female-to-male ratio was 4.7:1. The mean 
age for females was 32.6 years and for males 33.3 years. 
Most cases of papillary carcinoma, medullary carcinoma 
and follicular carcinoma were in patients in the fourth 
decade of life followed by the third and second decades 
(Table 2). However, poorly and undifferentiated carci-
nomas were seen between 40 to 70 years of age. 
DISCUSSION
Thyroid carcinomas represent the most common form 
of endocrine gland malignancy.12 Primary lymphomas 
of the thyroid are uncommon while other non-epithe-
lial malignancies are exceptionally rare.6 Variation in the 
frequency of thyroid carcinomas has been observed in 
various parts of the world. We found papillary carci-
noma as the commonest malignant lesion (90.2%). In 
the USA, Hay13 and Meier et al14 also reported a similar 
frequency of papillary carcinoma (90%). Other studies 
from Lahore,15 Yemen16 and Iran17 have also reported 
papillary carcinoma as the commonest malignant thy-
roid tumour with a variable frequency of 57.9%, 93.8% 
and 69.9%, respectively. The mean age of our patients 
was 32 years, which is slightly earlier as compared to 
Shah et al18 who found a mean age of 36.8 years.
Our study showed a predominancy of females 
(82.4%) in all carcinomas as compared with males 
(17.6%) with a female-to-male ratio of 4.7:1. Studies by 
several authors2,15,17 also show a female predominancy 
in thyroid cancers with a varying female-to-male ratio 
of 2.4:1, 4:1 and 3:1. This observation suggests that a 
specific susceptibility gene with sex hormone receptor 
elements may be involved in the pathogenesis of thyroid 
carcinoma. There is also expression of estrogen recep-
tors on neoplastic thyroid epithelium. Most of our pa-
tients were in the third and fourth decades of life, which 
is similar to data reported by Ahmed et al.15
The frequency of follicular carcinoma in our series 
was 2% (3 cases). However, a comparatively high fre-
quency was reported by Abu-Eshy et al,19 Hundahl et 
al20 and Abdullah21 as 4.2%, 10% and 21.5%, respective-
ly. For the diagnosis of follicular carcinoma strict criteria 
need to be followed for capsular and vascular invasion. 
There is an interobserver variation between patholo-
gists, which might be the reason for our small number of 
follicular carcinoma as compared to other studies.
The current study showed a frequency of medullary 
carcinoma of 4.5%, which is in agreement with a local 
study22 and a study from Saudi Arabia,19 the where re-
ported prevalences of medullary carcinoma were 4.21% 
and 4.2%, respectively.
Mixed medullary and follicular cell carcinoma is a 
Table 1. Distribution of 153 malignant lesions. 
Type No. of cases Percentage  
Papillary carcinoma 138 90.2
   Follicular 72 -
   Classic 61 -
   Micropapillary 5 -
Medullary carcinoma 7 4.5
   Follicular 3 -
   Paraganglioma-like 1 -
   Oncocytic cell 1 -
   Papillary 1 -
   Small cell 1 -
Follicular carcinoma 3 2
Undifferentiated carcinoma 3 2
Mixed medullary and papillary 
carcinoma 1 0.7
Poorly differentiated 
carcinoma 1 0.7
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rare tumur and most have been described in single case 
reports. We found a single case of mixed medullary and 
papillary carcinoma in a 25-year-old female. Our patient 
was young compared to a case reported by Al-Mashat23 
of a 40-year-old female with this malignant tumor.
Poorly differentiated carcinoma remains a contro-
versial entity, and it is therefore difficult to evaluate 
whether the different prevalence rates among differ-
ent geographic regions reflect true etiological differ-
ences or mere variations in diagnostic criteria.24 We 
reported a single case of poorly differentiated (insular) 
carcinoma (0.7%). This is not in accordance with a 
study from northern Pakistan where two (9.5%) cases 
of insular carcinoma were reported in a total of 21 ma-
lignant lesions.11 This high frequency could be due to 
a relatively smaller number of total cases examined. 
The current study showed 3 (2%) patients with un-
differentiated carcinoma, which is in accordance with 
the findings of Hussain et al22 who reported 3 (3.2%) 
 Table 2. age distribution of patients with 153 malignant lesions.
       
        Type
 Age groups
 Mean  
age10-20 
years
21-30 
years
31-40 
years
41-50 
years
51-60 
years
61-70 
years
Papillary carcinoma 26 43 48 16 5 - 32.0
Medullary carcinoma 1 2 4 - - - 35.3
Follicular carcinoma - - 2 1 - - 45.8
Undifferentiated carcinoma - - - 1 1 1 58.3
Mixed medullary and papillary 
carcinoma - 1 - - - - 25.0
Poorly differentiated carcinoma - - - 1 - - 50.0
Total 27 46 54 19 6 1 32.4
Minimum age: male-14 years, female-15 years; maximum age: male-60 yearrs, female-70 years
patients with this carcinoma in a total of 95 cases. 
All our patients were females and were diagnosed in 
the fifth, sixth and seventh decades of life, with mean 
age of 58.3 years. Studies by other workers2,17,20 have 
also reported a female predominance and an older age 
group for this carcinoma. 
The geographic variation in the prevalence rate of 
thyroid cancer could be attributed to the iodine content 
in food. It has been reported that after the introduction 
of iodine prophylaxis in various parts of the world, an 
increase in the relative frequency of papillary carcinoma 
over follicular carcinoma has been observed.25 Any sta-
tistical data about the disease draws attention towards 
the many important aspects like control, prevention and 
also for further research. Since this is a laboratory-based 
study, it has its own limitations. In this regard, a popu-
lation-based study and estimation of iodine content in 
water and food along with study of dietary habits in the 
community is suggested.
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